Skip to main content
. 2021 Jul 19;62(8):702–707. doi: 10.3349/ymj.2021.62.8.702

Table 1. Baseline Characteristics of the Study Groups.

NTM-PD (n=150) Control (n=217) p value
Age, yr 63.8±9.2 63.5±10.0 0.737
Sex, female 114 (76.0) 149 (68.7) 0.157
Height, cm 160.1±7.2 159.8±7.4 0.720
Weight, kg 53.3±8.0 58.8±9.9 <0.001
Body mass index, kg/m2 20.8±2.6 23.0±3.1 <0.001
Smoking 0.021
Current 1 (0.7) 12 (5.5)
Ex-smoker 26 (17.3) 47 (21.7)
Never 123 (82.0) 158 (72.8)
Pack-year 27.1±21.0 24.9±21.2 0.639
Comorbidities
Bronchiectasis 68 (45.3) 77 (35.5) 0.074
History of TB 42 (28.0) 40 (18.4) 0.042
GERD 39 (26.0) 32 (14.7) 0.011
COPD 20 (13.3) 35 (16.1) 0.556
Asthma 11 (7.3) 23 (10.6) 0.380
Diabetes mellitus 10 (6.7) 25 (11.5) 0.169
Interstitial lung diseases 2 (1.3) 22 (10.1) 0.002
Lung cancer 1 (0.7) 10 (4.6) 0.062
Menopause 103 (90.4) 130 (87.2) 0.556
Age at menopause, yr 49.9±4.7 49.3±6.6 0.394
Family history of TB 27 (18.0) 21 (9.7) 0.030
Family history of NTM 5 (3.3) 1 (0.5) 0.086

COPD, chronic obstructive pulmonary disease; GERD, gastroesophageal reflux disease; NTM, nontuberculous mycobacteria; NTM-PD, nontuberculous mycobacterial pulmonary disease; TB, tuberculosis.

Data are presented as numbers (%) or means±standard deviation.